Lifechanging Treatment for Cystic Fibrosis Patients has arrived in our province.
Ontario is now providing coverage for Trikafta – the latest and most effective treatment option for cystic fibrosis.
“Our government has taken urgent action to ensure all cystic fibrosis patients will have more timely access to the effective and lifechanging treatments they need,” said Christine Elliott, Deputy Premier and Minister of Health. “Providing coverage for Trikafta is one more way our government is building a sustainable, modern and connected health care system that will expand coverage to new and innovative treatments and provide high-quality health care to patients for years to come.”
The drug was approved by Health Canada in June this year.
President and CEO, of Cystic Fibrosis Canada, Kelly Grover, says the treatment is the single greatest innovation in cystic fibrosis history, and has the power to transform the lives of thousands of Canadians.
“The cystic fibrosis community in Ontario has fought long and hard to get this drug into their hands. Access to Trikafta will mean longer and healthier lives for so many people and the ability to plan for a future that many feared they might not live to see.”
It is estimated that one in every 3,600 children born in Canada, has cystic fibrosis.
